Genway
AI NativeSupercharge your research with AI
Published Oct 16, 2026
| Starting price | Direct minimum unverified; published enterprise bundle pricing available from a partner marketplace | Custom quote | Free workspace; published per-seat and plan pricing available from the vendor; interviews charged separately | Current retrieved pricing page directs buyers to sales; trial available |
| Intended use | Repeated AI-led customer conversations | Research teams seeking expert-supported AI studies | Smaller or intermittent projects requiring transparent purchasing | Broader usability and mixed-method product research |
| Documented capability | Interview-to-synthesis workflow; published international studies | Explicitly documented research services and broad language coverage | Public interview pricing model and free entry-level workspace | Prototype, information-architecture, website, and mobile research breadth |
| Limitation | Sparse independent reviews and incomplete public procurement detail | Opaque pricing; features/services vary by contract | Per-interview charges remain additional to paid workspace plans | Some capabilities are enterprise-gated; no current numeric price recovered from public materials |
| Security disclosure | SOC 2 badge, type unspecified | Explicit SOC 2 Type II claim and SSO | Scale tier lists SSO, SCIM, audit log | Explicit SOC 2 Type II claim |
The available practitioner account describes complementary use of Genway and Maze, not a complete replacement or confirmed migration. A competing vendor’s Genway-alternative article criticizes pricing visibility, but a recent characterization of trial and product access should not override current Genway disclosures.
Market share cannot be quantified from the reviewed evidence. Funding, named case studies, and company directories establish market participation, not adoption leadership. No reliable Genway revenue share, paid-seat share, win rate, or growth series was found.